Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Sonoma Pharmaceuticals, Inc.

NASDAQ: SNOA · Industrial Applications and Services · 3 alerts · CIK 1367083

Share price
$0.8802Close, Nov 16
Market cap
$4.46M
Shares outstanding
5.06MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Sonoma Pharmaceuticals, Inc. filings on SEC EDGAR ↗

4:02 PM ET 10-Q
Financial Results

Sonoma Pharmaceuticals Q2 2026 Results: Net Loss of $66K, Loss Narrows

Sonoma Pharmaceuticals reported a significant revenue increase to $13.58 million for the six months ended September 30, 2026, compared to $9.62 million in the prior year. The company successfully narrowed its net loss to $396,000 from $1.78 million, driven by improved gross profits and a return to positive income from operations in the most recent quarter.

Key figure
Net loss $66K
4:30 PM ET 8-K
Other 8-K Filing

Sonoma Pharmaceuticals Other 8-K Filing

Sonoma Pharmaceuticals adopted a Section 382 Rights Agreement (poison pill) to protect its net operating loss carryforwards (NOLs) from being limited by an 'ownership change'. The agreement issues one preferred stock purchase right for each share of common stock, intended to deter any person or group from acquiring 5% or more of the company's shares.

Counterparty
Computershare Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.